Navigation Links
Supply of Radiopharmaceuticals Hampered by Attacks

As a result of the September 11 terrorist acts in New York and Washington DC, air transportation in the United States was put on hold for several days, which severely affected the production and distribution of radiopharmaceuticals.

Most radiopharmaceuticals are shipped via air due to their specific nature. These products are either radioactive themselves or they are pharmaceuticals with a radioactive component, and are used in diagnosis or therapy based on the specific designs of these products.// As these products or their radioactive component decay, they become less valuable over time.

Because these products decay from the instant they are produced, air shipments are paramount for timely delivery to ensure proper processing. Once processed, the nuclear medicine industry relies heavily on air shipments to get these quality products into the hands of the specialty clinicians, mostly through nuclear pharmacies, so that appropriate medical care involving radiopharmaceuticals can be provided.

Mallinckrodt, a leading maker and supplier of radiopharmaceuticals, spent a large number of man-hours getting products in from outside the United States for processing, and even more time in arranging special line-haul trucks to carry finished products by ground to sites throughout the United States to maintain an adequate supplies. In addition, the company tried to ensure that the New York area could continue to get radiopharmaceuticals so that all possible treatment options would be open to the victims of the attacks.


'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
2. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
3. Chinese City Suspends Water Supply Fearing Pollution
4. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
5. Britain Approves Indian Company For Supplying Medicines
6. Shot Supply: Reduced Dosage of Seasonal flu Vaccine, Works!
7. US Firm To Supply Female Condoms To India
8. Already Short Staffed And In Deficit NHS Fails To Supply Staff For IT Project
9. WB Asks Centre To Continue Supply Of Anti-Rabies Vaccine
10. Ranbaxy Signs Licensing, Supply Agreement for Canadian Market
11. Blood Safety, Supply, and Innovations Addressed at Conference
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ealth Canada issued a warning that drugs used to t...hildren can cause// certain rare psychiatric side-...hallucination. The department has issued a ruling,...ts, that all drugs used to control ADHD, will need...
... recent study revealed that the risk of developmen...d be reduced by the intake of multivitamins in the... that multivitamins containing folic acid should b...y to reduce the risk of development of a neural tu...
...EIJING: The popularity of Chinese products leaves ... yet an average Chinese, caught up in the euphoria...ately not a symbol of good health. A survey purpo... health, set into motion by 10 organisations and c...
...early 600 doctors spread over various districts of...ment, leaving the medical community in the state f...istricts comes just weeks after the state governme...l transfers in all departments of the state. The...
Other Medicine News:Health News:Prenatal Multivitamins to prevent risk of Brain Tumors In Kids 2
(Date:9/3/2008)...alysis showed that Multaq(R) (dronedarone) decreas...l fibrillation or atrial flutter already ... BRIDGEWATER, N.J., Sept. 3 /PRNewswire-FirstCall/... from the ATHENA study were presented today at,the...iety of Cardiology,congress 2008, in Munich, Germa...
(Date:9/3/2008)...09 to be Evaluated in Repeat-Dosing Study in Subje...re-FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq...se,2 clinical trial (SB-509-801) to evaluate its d...degenerative motor-neuron disease for which there,...mo,s drug, SB-509, is an injectable formulation of...
(Date:9/2/2008)...elegates Join World Vision, ONE to Build Hope and ...swire/ -- Delegates to the,Republican Party Conven...communities around the world including evacuees in...V and AIDS in developing countries: "We are here,t...nviting party delegates to do,something unconventi...
(Date:9/2/2008)...t of three ongoing randomized chemotherapy combina...atment of specific cancers -, ROCKVILLE, Md., Sep...es, Inc. (Nasdaq: HGSI ) today reported initial t...clinical trial of its TRAIL receptor antibody,HGS-...(Velcade) in patients,with advanced multiple myelo...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 1AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 2AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 3Antioxidant users dont live longer analysis of studies concludes 2904 1Antioxidant users dont live longer analysis of studies concludes 2904 2Antioxidant users dont live longer analysis of studies concludes 2904 3Hereditary breast cancer a high cost to patient and health care provider alike 16918 1Hereditary breast cancer a high cost to patient and health care provider alike 16918 2Hereditary breast cancer a high cost to patient and health care provider alike 16918 3Senetek PLC Reports 2007 Financial Results 16915 1Senetek PLC Reports 2007 Financial Results 16915 2Senetek PLC Reports 2007 Financial Results 16915 3
...07. Giaconda Ltd (ASX: GIA) today,announced that t...ved the Company,s Investigational New Drug applica...aR to treat patients with,Crohn,s Disease infected...P). , ,The Company understands that its lead produ...d to the FDA for this indication. There,are no ant...
..., 2007 /PRNewswire-FirstCall/ --,Allos Therapeutic...,European Communities, with a favorable opinion of...e European Medicines Agency (EMEA),has granted or...olate PDX (pralatrexate) for the treatment of pati...ly 2006, the U.S. Food and,Drug Administration (FD...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
...iCharts, is a state-of-the-art electronic medical ...8. It is a proven, comprehensive electronic medica...are providers at the point of care and to be share...nternet. AmkaiCharts chronicles patient history, e...
...fice seamlessly integrates practice management and...nd clinical workflow. Instantly access registratio...eporting information for multiple practices, provi...tely improves productivity by simplifying office w...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes
...e is an important movement in our country to provi...ns. In fact, recent government regulations require...s device affords your wheelchair-bound patients ea...t without having to leave their wheelchair. , ,The...
Medicine Products: